Plain-English translation of NCT06654453 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether removing blood clots during a heart procedure called percutaneous coronary intervention (PCI) helps patients recover better after a heart attack. You would have already received medication to break up clots, and this study asks whether adding a clot-removal step to the standard artery-opening procedure improves your outcomes over the next month.
After a heart attack, doctors use clot-busting medications followed by a procedure to open blocked arteries, but sometimes clots remain and can damage the heart muscle. This trial is exploring whether removing those remaining clots during the procedure leads to better recovery and fewer complications.
You likely qualify if…
You likely don't qualify if…
After you receive your initial clot-busting medication, you'll be randomly assigned to one of two groups: one group will receive the standard artery-opening procedure alone, while the other group will have clots removed first and then receive the same artery-opening procedure. Either way, you'll be monitored closely for 30 days afterward to check how well you're recovering and whether you experience any complications.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
China